


Unavailable
Type: AH - Commercial Vaccine
Species: Swine
MycoMAX is the first Mhr vaccine for pigs with demonstrated efficacy and safety. It offers:
Proven to protect against arthritis, pericarditis, lameness, and peritonitis associated with Mhr
Effectively protects pigs in the nursery phase, when they are most susceptible to Mhr infection resulting in clinical disease
Pig’s average daily gain three weeks following challenge demonstrated a highly significant statistical increase in post-challenge weight gain (P < .0001) of 0.42 kg/day vs Controls at 0.26 kg/day
Facilitates a control program that supports good antibiotic stewardship practices
Ingelvac® and MycoMAX are registered trademarks of Boehringer Ingelheim Animal Health USA, Inc.